Dillon R, Hills RK, Burnett AK, Russell NH, et al. Gemtuzumab ozogamicin in (KMT2A)-rearranged adult acute myeloid leukaemia (AML) in the UK Medical Research Council AML15 and AML16 trials. Br J Haematol 2022;196:e50-e52.
PMID: 34799856